Ghrelin, peptide YY and their hypothalamic targets differentially regulate spontaneous physical activity

Physiology and Behavior

Volumn 105, Issue 1, 2011, Pages 52-61

  Pfluger, Paul T ^a   Castañeda, Tamara R ^a,c   Heppner, Kristy M ^a   Strassburg, Sabine ^a   Kruthaupt, Traci ^a   Chaudhary, Nilika ^a   Halem, Heather ^b   Culler, Michael D ^b   Datta, Rakesh ^b   Burget, Lukas ^a,d   Tschop M H ^a   Nogueiras, Ruben ^a,e   Perez Tilve, Diego ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b Biomeasure Inc   (United States)

^c UNIVERSITY OF TOLEDO   (United States)

^d LUZERNER KANTONSSPITAL   (Switzerland)

^e UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

AgRP; Ghrelin; Locomotion; NPY; Spontaneous physical activity

Indexed keywords

AGOUTI RELATED PROTEIN; ALPHA INTERMEDIN; GHRELIN; NUCLEAR FACTOR Y; PEPTIDE YY [3-36];

ANALYZER; ANIMAL EXPERIMENT; ARTICLE; BODY COMPOSITION; BODY WEIGHT; CONTROLLED STUDY; ENERGY BALANCE; FOOD INTAKE; LOCOMOTION; MALE; MOUSE; NEUROMODULATION; NONHUMAN; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; SPONTANEOUS PHYSICAL ACTIVITY;

AGOUTI-RELATED PROTEIN; ANIMALS; BEHAVIOR, ANIMAL; BODY COMPOSITION; EATING; GHRELIN; HYPOTHALAMUS; MALE; MOTOR ACTIVITY; NEUROPEPTIDE Y; PEPTIDE YY; PRO-OPIOMELANOCORTIN; RATS; RATS, LONG-EVANS; RATS, SPRAGUE-DAWLEY;

EID: 80053456531     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2011.04.025     Document Type: Article

References (50)

1. Levine J.A., Lanningham-Foster L.M., McCrady S.K., Krizan A.C., Olson L.R., Kane P.H., et al. Interindividual variation in posture allocation: possible role in human obesity. Science 2005, 307:584-586.
2. Levine J.A., Eberhardt N.L., Jensen M.D. Role of nonexercise activity thermogenesis in resistance to fat gain in humans. Science 1999, 283:212-214.
3. Pelleymounter M.A., Cullen M.J., Baker M.B., Hecht R., Winters D., Boone T., et al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995, 269:540-543.
4. Licinio J., Caglayan S., Ozata M., Yildiz B.O., de Miranda P.B., O'Kirwan F., et al. Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults. Proc Natl Acad Sci U S A 2004, 101:4531-4536.
5. Coppari R., Ichinose M., Lee C.E., Pullen A.E., Kenny C.D., McGovern R.A., et al. The hypothalamic arcuate nucleus: a key site for mediating leptin's effects on glucose homeostasis and locomotor activity. Cell Metab 2005, 1:63-72.
6. Kirchner H., Gutierrez J.A., Solenberg P.J., Pfluger P.T., Czyzyk T.A., Willency J.A., et al. GOAT links dietary lipids with the endocrine control of energy balance. Nat Med 2009, 15:741-745.
7. Gutierrez J.A., Solenberg P.J., Perkins D.R., Willency J.A., Knierman M.D., Jin Z., et al. Ghrelin octanoylation mediated by an orphan lipid transferase. Proc Natl Acad Sci USA 2008, 105:6320-6325.
8. Tschop M., Smiley D.L., Heiman M.L. Ghrelin induces adiposity in rodents. Nature 2000, 407:908-913.
9. Kirchner H., Tong J., Tschop M.H., Pfluger P.T. Ghrelin and PYY in the regulation of energy balance and metabolism: lessons from mouse mutants. Am J Physiol Endocrinol Metab 2010, 298:E909-E919.
10. Andrews Z.B., Liu Z.W., Walllingford N., Erion D.M., Borok E., Friedman J.M., et al. UCP2 mediates ghrelin's action on NPY/AgRP neurons by lowering free radicals. Nature 2008, 454:846-851.
11. Cowley M.A., Smith R.G., Diano S., Tschop M., Pronchuk N., Grove K.L., et al. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 2003, 37:649-661.
12. Kamegai J., Tamura H., Shimizu T., Ishii S., Sugihara H., Wakabayashi I. Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and Agouti-related protein mRNA levels and body weight in rats. Diabetes 2001, 50:2438-2443.
13. Nakazato M., Murakami N., Date Y., Kojima M., Matsuo H., Kangawa K., et al. A role for ghrelin in the central regulation of feeding. Nature 2001, 409:194-198.
14. Egecioglu E., Stenstrom B., Pinnock S.B., Tung L.Y., Dornonville de la Cour C., Lindqvist A., et al. Hypothalamic gene expression following ghrelin therapy to gastrectomized rodents. Regul Pept 2008, 146:176-182.
15. Arnold M., Mura A., Langhans W., Geary N. Gut vagal afferents are not necessary for the eating-stimulatory effect of intraperitoneally injected ghrelin in the rat. J Neurosci 2006, 26:11052-11060.
16. Tang-Christensen M., Vrang N., Ortmann S., Bidlingmaier M., Horvath T.L., Tschop M. Central administration of ghrelin and agouti-related protein (83-132) increases food intake and decreases spontaneous locomotor activity in rats. Endocrinology 2004, 145:4645-4652.
17. Batterham R.L., Bloom S.R. The gut hormone peptide YY regulates appetite. Ann NY Acad Sci 2003, 994:162-168.
18. Batterham R.L., Cowley M.A., Small C.J., Herzog H., Cohen M.A., Dakin C.L., et al. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 2002, 418:650-654.
19. Boggiano M.M., Chandler P.C., Oswald K.D., Rodgers R.J., Blundell J.E., Ishii Y., et al. PYY3-36 as an anti-obesity drug target. Obes Rev 2005, 6:307-322.
20. Pfluger P.T., Kampe J., Castaneda T.R., Vahl T., D'Alessio D.A., Kruthaupt T., et al. Effect of human body weight changes on circulating levels of peptide YY and peptide YY3-36. J Clin Endocrinol Metab 2007, 92:583-588.
21. Tschop M., Castaneda T.R., Joost H.G., Thone-Reineke C., Ortmann S., Klaus S., et al. Physiology: does gut hormone PYY3-36 decrease food intake in rodents?. Nature 2004, 430. 1 p following 165; discussion 2 p following.
22. Challis B.G., Pinnock S.B., Coll A.P., Carter R.N., Dickson S.L., O'Rahilly S. Acute effects of PYY3-36 on food intake and hypothalamic neuropeptide expression in the mouse. Biochem Biophys Res Commun 2003, 311:915-919.
23. Halatchev I.G., Cone R.D. Peripheral administration of PYY(3-36) produces conditioned taste aversion in mice. Cell Metab 2005, 1:159-168.
24. Strassburg S., Anker S.D., Castaneda T.R., Burget L., Perez-Tilve D., Pfluger P.T., et al. Long-term effects of ghrelin and ghrelin receptor agonists on energy balance in rats. Am J Physiol Endocrinol Metab 2008, 295:E78-E84.
25. Keire D.A., Bowers C.W., Solomon T.E., Reeve J.R. Structure and receptor binding of PYY analogs. Peptides 2002, 23:305-321.
26. Nogueiras R., Wiedmer P., Perez-Tilve D., Veyrat-Durebex C., Keogh J.M., Sutton G.M., et al. The central melanocortin system directly controls peripheral lipid metabolism. J Clin Invest 2007, 117:3475-3488.
27. Theander-Carrillo C., Wiedmer P., Cettour-Rose P., Nogueiras R., Perez-Tilve D., Pfluger P., et al. Ghrelin action in the brain controls adipocyte metabolism. J Clin Invest 2006, 116:1983-1993.
28. Cummings D.E. Ghrelin and the short- and long-term regulation of appetite and body weight. Physiol Behav 2006, 89:71-84.
29. Pfluger P.T., Kirchner H., Gunnel S., Schrott B., Perez-Tilve D., Fu S., et al. Simultaneous deletion of ghrelin and its receptor increases motor activity and energy expenditure. Am J Physiol Gastrointest Liver Physiol 2008, 294:G610-G618.
30. Ste Marie L., Miura G.I., Marsh D.J., Yagaloff K., Palmiter R.D. A metabolic defect promotes obesity in mice lacking melanocortin-4 receptors. Proc Natl Acad Sci USA 2000, 97:12339-12344.
31. Wortley K.E., Anderson K.D., Yasenchak J., Murphy A., Valenzuela D., Diano S., et al. Agouti-related protein-deficient mice display an age-related lean phenotype. Cell Metab 2005, 2:421-427.
32. de Backer M.W., la Fleur S.E., Brans M.A., van Rozen A.J., Luijendijk M.C., Merkestein M., et al. Melanocortin receptor-mediated effects on obesity are distributed over specific hypothalamic regions. Int J Obes (Lond) 2010, 1-13.
33. Strader A.D., Reizes O., Woods S.C., Benoit S.C., Seeley R.J. Mice lacking the syndecan-3 gene are resistant to diet-induced obesity. J Clin Invest 2004, 114:1354-1360.
34. Reizes O., Benoit S.C., Strader A.D., Clegg D.J., Akunuru S., Seeley R.J. Syndecan-3 modulates food intake by interacting with the melanocortin/AgRP pathway. Ann NY Acad Sci 2003, 994:66-73.
35. Riediger T., Traebert M., Schmid H.A., Scheel C., Lutz T.A., Scharrer E. Site-specific effects of ghrelin on the neuronal activity in the hypothalamic arcuate nucleus. Neurosci Lett 2003, 341:151-155.
36. Pritchard L.E., White A. Neuropeptide processing and its impact on melanocortin pathways. Endocrinology 2007, 148:4201-4207.
37. Neary M.T., Batterham R.L. Peptide YY: food for thought. Physiol Behav 2009, 97:616-619.
38. Broberger C., Landry M., Wong H., Walsh J.N., Hokfelt T. Subtypes Y1 and Y2 of the neuropeptide Y receptor are respectively expressed in pro-opiomelanocortin- and neuropeptide-Y-containing neurons of the rat hypothalamic arcuate nucleus. Neuroendocrinology 1997, 66:393-408.
39. Parker R.M., Herzog H. Regional distribution of Y-receptor subtype mRNAs in rat brain. Eur J Neurosci 1999, 11:1431-1448.
40. Vrang N., Madsen A.N., Tang-Christensen M., Hansen G., Larsen P.J. PYY(3-36) reduces food intake and body weight and improves insulin sensitivity in rodent models of diet-induced obesity. Am J Physiol Regul Integr Comp Physiol 2006, 291:R367-R375.
41. Redrobe J.P., Dumont Y., Herzog H., Quirion R. Neuropeptide Y (NPY) Y2 receptors mediate behaviour in two animal models of anxiety: evidence from Y2 receptor knockout mice. Behav Brain Res 2003, 141:251-255.
42. Edelsbrunner M.E., Herzog H., Holzer P. Evidence from knockout mice that peptide YY and neuropeptide Y enforce murine locomotion, exploration and ingestive behaviour in a circadian cycle- and gender-dependent manner. Behav Brain Res 2009, 203:97-107.
43. Heilig M., Murison R. Intracerebroventricular neuropeptide Y suppresses open field and home cage activity in the rat. Regul Pept 1987, 19:221-231.
44. Pedrazzini T., Seydoux J., Kunstner P., Aubert J.F., Grouzmann E., Beermann F., et al. Cardiovascular response, feeding behavior and locomotor activity in mice lacking the NPY Y1 receptor. Nat Med 1998, 4:722-726.
45. Bannon A.W., Seda J., Carmouche M., Francis J.M., Norman M.H., Karbon B., et al. Behavioral characterization of neuropeptide Y knockout mice. Brain Res 2000, 868:79-87.
46. Abizaid A., Liu Z.W., Andrews Z.B., Shanabrough M., Borok E., Elsworth J.D., et al. Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite. J Clin Invest 2006, 116:3229-3239.
47. Jerlhag E. Systemic administration of ghrelin induces conditioned place preference and stimulates accumbal dopamine. Addict Biol 2008, 13:358-363.
48. Jerlhag E., Egecioglu E., Dickson S.L., Douhan A., Svensson L., Engel J.A. Ghrelin administration into tegmental areas stimulates locomotor activity and increases extracellular concentration of dopamine in the nucleus accumbens. Addict Biol 2007, 12:6-16.
49. Jerlhag E., Egecioglu E., Dickson S.L., Andersson M., Svensson L., Engel J.A. Ghrelin stimulates locomotor activity and accumbal dopamine-overflow via central cholinergic systems in mice: implications for its involvement in brain reward. Addict Biol 2006, 11:45-54.
50. Jerlhag E., Egecioglu E., Dickson S.L., Engel J.A. Ghrelin receptor antagonism attenuates cocaine- and amphetamine-induced locomotor stimulation, accumbal dopamine release, and conditioned place preference. Psychopharmacology (Berl) 2010, 211:415-422.